Quarterly report pursuant to Section 13 or 15(d)

STOCK COMPENSATION (Tables)

v3.22.0.1
STOCK COMPENSATION (Tables)
9 Months Ended
Dec. 31, 2021
Equity [Abstract]  
Share-based compensation expense relating to RSUs
               
    Three Months
Ended
December 31,
2021
  Three Months
Ended
December 31,
2020
  Nine Months
Ended
December 31,
2021
  Nine Months
Ended
December 31,
2020
Vesting of stock options and restricted stock units   $ 201,019     $ 377,958     $ 522,234     $ 629,207  
Total stock-based compensation expense   $ 201,019     $ 377,958     $ 522,234     $ 629,207  
                                 
Weighted average number of common shares outstanding – basic and diluted     15,397,418       12,093,361       14,543,787       11,265,725  
                                 
Basic and diluted loss per common share attributable to stock-based compensation expense   $ (0.01 )   $ (0.03 )   $ (0.04 )   $ (0.06 )
Options outstanding that have vested and are expected to vest
           
    Number of
Shares
  Weighted
Average
Exercise
Price
  Weighted
Average
Remaining
Contractual
Term in
Years
Vested     166,717     $ 2.92       8.43  
Expected to vest     824,931     $ 2.93       8.97  
Total     991,648                  
Schedule of stock option activity
           
    Amount   Range of
Exercise Price
  Weighted
Average
Exercise
Price
Stock options outstanding at March 31, 2021     844,089     $ 1.28 - 142.50     $ 3.07  
Exercised     (11,562 )   $ 2.45     $ 2.45  
Granted     266,888     $ 5.17     $ 5.17  
Cancelled/Expired     (107,767 )   $ 2.45 – 142.50     $ 9.66  
Stock options outstanding at December 31, 2021     991,648     $ 1.28 - 142.50     $ 2.93  
Stock options exercisable at December 31, 2021     166,717     $ 1.28 - 142.50     $ 2.92